                </a></li></ul></div><p><strong>Figure 4.  <span>Exacerbation of amyloid load by genetic combination of lack of <em>sod2</em> and overexpression of APP.</span></strong></p><a id="article1.body1.sec3.sec3.fig1.caption1.p1" name="article1.body1.sec3.sec3.fig1.caption1.p1"></a><p>(a) Immunohistochemistry quantitation (area occupied by Aß/mm2) did not demonstrate any significant alterations in total Aß plaque burden, although there is an ~30% increase (p = 0.2) in plaques in the Tg2576:<em>sod2</em> animals as compared to other groups. (b) ELISA quantitation demonstrates that EUK189 treatment significantly modulates Aß levels. Furthermore, genetically combining lack of <em>sod2</em> with overexpression of mutant APP elevates Aß levels in the Tg2576 mouse. The data indicate mean±SD.</p>
<span>THISISTHEEND
